Pfizer

OverviewSuggest Edit

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. It operates in two business segments: Pfizer Biopharmaceuticals Group (Biopharma) and Upjohn. The Biopharma segment offers medicines, vaccines, and biosimilars for the treatment of cardiovascular and metabolic diseases, oncology diseases, pneumococcal disease, meningococcal disease and tick-borne encephalitis, chronic immune and inflammatory diseases, as well as rare diseases, including amyloidosis, hemophilia, and endocrine diseases. The Upjohn segment provides products that are used to treat non-communicable diseases across a range of therapeutic areas, including cardiovascular, pain and neurology, psychiatry, urology, and ophthalmology.

TypePublic
Founded1849
HQNew York, NY, USMap
Websitepfizer.com
Employee Ratings4.2More
Overall CultureBMore
View Jobs (1,729)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)88,300(-4%)
Job Openings1,729
Revenue (FY, 2020)$41.9 B(-19%)
Share Price (Sept 2021)$44.8
Cybersecurity ratingCMore

Key People/Management at Pfizer

Albert Bourla

Albert Bourla

Chairman & Chief Executive Officer
Frank D'Amelio

Frank D'Amelio

Chief Financial Officer and Executive Vice President, Global Supply
Mikael Dolsten

Mikael Dolsten

Chief Scientific Officer and President, Worldwide Research, Development and Medical
Lidia Fonseca

Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President
Rod MacKenzie

Rod MacKenzie

Chief Development Officer, Executive Vice President
Angela Hwang

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group
Show more

Pfizer Office Locations

Pfizer has offices in New York, Andover, Boulder, Cambridge and in 92 other locations
New York, NY, US (HQ)
235 E 42nd St
Andover, MA, US
1 Burtt Rd
Boulder, CO, US
3200 Walnut St
Cambridge, MA, US
1 Portland St
Chesterfield, MO, US
875 Chesterfield Pkwy W
Collegeville, PA, US
500 Arcola Rd
Show all (101)

Pfizer Financials and Metrics

Pfizer Revenue

Embed Graph
View revenue for all periods
Pfizer's revenue was reported to be $41.91 b in FY, 2020
USD

Revenue (Q1, 2021)

14.6b

Gross profit (Q1, 2021)

10.4b

Gross profit margin (Q1, 2021), %

71.1%

Net income (Q1, 2021)

4.9b

Market capitalization (15-Sept-2021)

250.6b

Closing stock price (15-Sept-2021)

44.8

Cash (4-Apr-2021)

1.8b

EV

288.5b
Pfizer's current market capitalization is $250.6 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

52.5b53.6b51.8b41.9b

Revenue growth, %

(1%)2%(4%)

Cost of goods sold

11.2b11.2b10.2b8.7b

Gross profit

41.3b42.4b41.5b33.2b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

12.9b13.5b13.3b13.1b13.3b12.7b12.0b11.8b12.1b14.6b

Cost of goods sold

2.6b2.9b2.7b2.4b2.6b2.6b2.4b2.3b2.5b4.2b

Gross profit

10.3b10.6b10.6b10.7b10.7b10.1b9.7b9.5b9.6b10.4b

Gross profit Margin, %

80%78%80%81%81%79%80%81%79%71%
show all
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

1.3b1.1b1.3b1.8b

Accounts Receivable

8.2b8.0b8.7b7.9b

Inventories

7.6b7.5b8.3b8.0b

Current Assets

41.1b49.9b32.8b35.1b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

2.3b2.7b3.6b1.9b1.8b2.8b2.2b1.8b1.6b1.8b

Accounts Receivable

9.5b9.9b10.0b9.6b9.8b9.4b9.9b9.1b10.0b9.9b

Inventories

8.1b8.1b8.2b8.0b8.2b8.2b8.4b8.6b9.3b8.5b

Current Assets

34.8b37.3b41.6b45.3b47.1b33.5b34.7b46.4b47.7b39.5b
show all
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

21.4b11.2b16.3b9.7b

Depreciation and Amortization

6.3b6.4b6.0b

Inventories

(357.0m)(717.0m)(1.0b)(736.0m)

Accounts Payable

46.0m431.0m(564.0m)353.0m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

3.6b7.4b11.6b3.9b8.9b16.6b3.4b6.8b9.0b4.9b

Depreciation and Amortization

1.6b3.1b4.7b1.5b3.1b4.6b1.2b2.5b3.7b

Cash From Operating Activities

2.0b5.8b11.1b1.7b4.3b8.8b3.1b6.7b8.8b4.5b

Purchases of PP&E

(386.0m)(810.0m)(1.4b)(460.0m)(939.0m)(1.5b)(463.0m)(942.0m)(1.5b)(554.0m)
show all
USDFY, 2017

Revenue/Employee

582.5k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.4 x
Show all financial metrics

Pfizer Operating Metrics

Pfizer's Properties was reported to be 453 in FY, 2019.
FY, 2017FY, 2018FY, 2019

Countries

125125125

Manufacturing Sites

585849

Properties

501498453

Products with >$1B Annual Revenue

9108
Show all operating metrics

Pfizer Acquisitions / Subsidiaries

Company NameDateDeal Size
Array BioPharmaJune 18, 2019$11.4 b
TherachonMay 08, 2019$340 m
MedivationAugust 22, 2016$14 b
Bamboo TherapeuticsAugust 01, 2016$654 m
BIND Therapeutics, Inc.July 27, 2016$40 m
Anacor PharmaceuticalsJune 24, 2016$5.2 b
HospiraFebruary 05, 2015$15 b
RedvaxJanuary 05, 2015
Baxter International - Marketed VaccinesJuly 30, 2014$635 m
InnoPharmaJuly 16, 2014$225 m
Show more

Pfizer Revenue Breakdown

Embed Graph

Pfizer revenue breakdown by business segment: 19.8% from Upjohn, 76.2% from Biopharma and 4.1% from Other

Pfizer revenue breakdown by geographic segment: 16.8% from Developed Europe, 46.1% from United States, 24.6% from Emerging Markets and 12.5% from Developed Rest of World

Pfizer Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

Learn more about our premium products
SecurityScorecard logo

Pfizer Online and Social Media Presence

Pfizer's Trends

Embed Graph

Pfizer Company Culture

  • Overall Culture

    B

    69/100

  • CEO Rating

    C+

    68/100

  • Compensation

    B

    72/100

  • Diversity

    B-

    68/100

Learn more on Comparably

Pfizer News and Updates

September 16, 2021

Here’s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month

A few weeks back, we discussed that Pfizer’s (NYSE: PFE) stock price could rebound over a one-month period after falling 4% in a week, based on its historical performance. However, PFE stock has seen a decline of over 6% since then, and it is down 4% in the last five trading days...
September 16, 2021

Pfizer Vaccine Still Effective, FDA Says Days Before Review Of Booster Proposal

The Biden administration has planned to launch a booster shot campaign for the general public as early as next week.
September 16, 2021

Losing Covid-19 antibody immunity after six months after Pfizer vaccine

Comments
September 15, 2021

Pfizer, Moderna Tout Boosters; Singapore’s Program: Virus Update

Track the global Covid-19 pandemic and vaccination efforts here.
September 15, 2021

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote Friday

People who have been vaccinated seem to be well-protected without a booster, agency staff said.
September 15, 2021

Pfizer submits data to FDA showing side effects from Covid booster shots are similar to second dose

Show more

Pfizer Blogs

August 04, 2021

Jnana Therapeutics

Jnana Therapeutics carterda Wed, 08/04/2021 - 15:07 Category Active Portfolio Companies Jnana Therapeutics is building the first small molecule drug discovery platform dedicated to SLC transporters, an ancient membrane protein family thought to be relev…
March 26, 2021

Pyxis Oncology

Pyxis Oncology carterda Fri, 03/26/2021 - 12:57 Category Active Portfolio Companies Pyxis Oncology is building a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with …
March 26, 2021

National Resilience

National Resilience carterda Fri, 03/26/2021 - 09:44 Category Active Portfolio Companies RESILIENCE is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply c…
March 26, 2021

Mediar Therapeutics

Mediar Therapeutics carterda Fri, 03/26/2021 - 09:44 Category Active Portfolio Companies Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis. The platform and pipeline are based on an emerging c…
December 27, 2020

INDEPENDENT MEDICAL EDUCATION

INDEPENDENT MEDICAL EDUCATION kimkevin Sat, 12/26/2020 - 19:36 Pfizer offers funding for independent medical education activities or initiatives which serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of a healthcare professional (e.g. conti…

 Pfizer Frequently Asked Questions

  • When was Pfizer founded?

    Pfizer was founded in 1849.

  • Who are Pfizer key executives?

    Pfizer's key executives are Albert Bourla, Frank D'Amelio and Mikael Dolsten.

  • How many employees does Pfizer have?

    Pfizer has 88,300 employees.

  • What is Pfizer revenue?

    Latest Pfizer annual revenue is $41.9 b.

  • What is Pfizer revenue per employee?

    Latest Pfizer revenue per employee is $474.6 k.

  • Who are Pfizer competitors?

    Competitors of Pfizer include Merck, Bausch Health and Astellas Pharma.

  • Where is Pfizer headquarters?

    Pfizer headquarters is located at 235 E 42nd St, New York.

  • Where are Pfizer offices?

    Pfizer has offices in New York, Andover, Boulder, Cambridge and in 92 other locations.

  • How many offices does Pfizer have?

    Pfizer has 101 offices.